Hypoxia activated prodrugs, such as, e.g., TH-281, TH-302, and TH-308, are useful for the treatment of various blood cancers, such as acute leukemias, chronic leukemias, MDS, MF, and multiple myeloma.
申请公布号
US2013296273(A1)
申请公布日期
2013.11.07
申请号
US201113806088
申请日期
2011.06.27
申请人
CURD KAREN;THRESHOLD PHARMACEUTICALS, INC.
发明人
CURD JOHN;HANDISIDES DAMIAN;HART CHARLES;KROLL STEWART
